Bone marrow changes induced by recombinant granulocyte colony-stimulating factor resembling metastatic carcinoma: distinction with cytochemical and immunohistochemical studies.
Pekarske
S L
SL
Shin
S S
SS
D000328:Adult; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D015415:Biomarkers; D014408:Biomarkers, Tumor / Q000032:analysis; D001853:Bone Marrow / Q000187:drug effects* / Q000473:pathology; D001856:Bone Marrow Examination / Q000379:methods*; D016026:Bone Marrow Transplantation; D001943:Breast Neoplasms / Q000473:pathology* / Q000628:therapy; D018270:Carcinoma, Ductal, Breast / Q000175:diagnosis* / Q000473:pathology / Q000556:secondary* / Q000628:therapy; D003131:Combined Modality Therapy; D003520:Cyclophosphamide / Q000008:administration & dosage / Q000009:adverse effects; D003937:Diagnosis, Differential; D004317:Doxorubicin / Q000008:administration & dosage / Q000009:adverse effects; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage / Q000009:adverse effects; D016179:Granulocyte Colony-Stimulating Factor / Q000494:pharmacology* / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000201:enzymology / Q000648:ultrastructure; D006801:Humans; D006984:Hypertrophy; D007155:Immunologic Factors / Q000494:pharmacology* / Q000627:therapeutic use; D009195:Peroxidase / Q000032:analysis*; D055728:Primary Myelofibrosis / Q000139:chemically induced / Q000175:diagnosis* / Q000473:pathology; D011994:Recombinant Proteins / Q000494:pharmacology
D015415:Biomarkers; D014408:Biomarkers, Tumor; D007155:Immunologic Factors; D011994:Recombinant Proteins; D016179:Granulocyte Colony-Stimulating Factor; D004317:Doxorubicin; D003520:Cyclophosphamide; D009195:Peroxidase; D005472:Fluorouracil